【coin界】Biopharmaceutical company Synaptogenix (NASDAQ: SNPX) announced its first purchase of TAO, with the specific purchase amount undisclosed. This is part of the company’s recent announcement of a financial strategy focused on artificial intelligence (AI) and machine learning Cryptocurrency, which will choose a certain platform to provide qualified accomplice management, stake, and trading services for Synaptogenix’s TAO assets.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Pharmaceutical giant Synaptogenix makes first purchase of TAO to lay out AI and machine learning strategies
【coin界】Biopharmaceutical company Synaptogenix (NASDAQ: SNPX) announced its first purchase of TAO, with the specific purchase amount undisclosed. This is part of the company’s recent announcement of a financial strategy focused on artificial intelligence (AI) and machine learning Cryptocurrency, which will choose a certain platform to provide qualified accomplice management, stake, and trading services for Synaptogenix’s TAO assets.